Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Azitra, Inc.AZTR · Entity 7959 | Director | December 19, 2025 | December 22, 2025 |
| INVO Fertility, Inc.IVF · Entity 8473 | Director | August 26, 2025 | August 29, 2025 |
| Indivior Pharmaceuticals, Inc.INDV · Entity 4040 | Director | May 13, 2026 | May 14, 2026 |
| MiNK Therapeutics, Inc.INKT · Entity 52 | Director | September 01, 2026 | September 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Azitra, Inc.
Report date December 19, 2025 · Filed December 22, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Right To Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.30 · Expires 2035-12-19 | Direct | 3,003 |
Reported balance
After 2025-12-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-12-19 · Grant · Acquired 3,003 · Balance 3,003 F1: 25% of the shares of the Company's Common Stock subject to the Option shall vest on the date of issuance, the Vesting Commencement Date, and the remaining balance shall vest in equal monthly installments over the next 36 months of continuous service thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% of the shares of the Company's Common Stock subject to the Option shall vest on the date of issuance, the Vesting Commencement Date, and the remaining balance shall vest in equal monthly installments over the next 36 months of continuous service thereafter.
INVO Fertility, Inc.
Report date August 26, 2025 · Filed August 29, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.01 · Expires 2035-08-26 | Direct | 45,157 |
Reported balance
After 2025-08-26 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-08-26 · Grant · Acquired 45,000 · Balance 45,157 F1: The option vests in four equal installments beginning on the first day of the calendar quarter following August 26, 2025 and on the first day of each calendar quarter thereafter until fully vested. |
| Common StockSEC Table I · non-derivative | Direct | 46 |
Reported balance
Holding disclosure · report date 2025-08-26 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 46 |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in four equal installments beginning on the first day of the calendar quarter following August 26, 2025 and on the first day of each calendar quarter thereafter until fully vested.
Indivior Pharmaceuticals, Inc.
Report date May 13, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,242 |
Reported balance
After 2026-05-13 transaction · row 1
1 source rowRow 1 · 2026-05-13 · Grant · Acquired 6,518 · Balance 12,242 F1: Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.
MiNK Therapeutics, Inc.
Report date September 01, 2026 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,591 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Grant · Acquired 1,622 · Balance 23,591 F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2026 Filed Sep 2, 2026 14:19 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantCommon Stock | 1,622 | $10.95 | $17,760.90 |
DisclosureSEC source: 0001193125-26-379518 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,591 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 22:04 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | SaleCommon Stock | 1,000 | $12.80 | $12,799.50 |
DisclosureSEC source: 0001193125-26-260084 · ownership.xml · nonDerivative · entry 2 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,969 F1 · security: The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 22:04 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | SaleCommon Stock | 500 | $12.68 | $6,341.75 |
DisclosureSEC source: 0001193125-26-260084 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,969 F1 · security: The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 20:05 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantCommon Stock | 1,434 | $12.38 | $17,752.92 |
DisclosureSEC source: 0001193125-26-253470 · ownership.xml · nonDerivative · entry 2 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,469 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. Read SEC document |
| May 13, 2026 Filed May 14, 2026 20:07 UTC | Indivior Pharmaceuticals, Inc. INDV · Entity 4040 | GrantCommon Stock | 6,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001827169-26-000013 · wk-form4_1778789272.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,242 F1 · shares: Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date. Read SEC document |
| March 13, 2026 Filed Mar 13, 2026 20:25 UTC | Indivior Pharmaceuticals, Inc. INDV · Entity 4040 | PurchaseCommon Stock | 8 | $31.09 | $248.68 |
DisclosureSEC source: 0001827169-26-000010 · wk-form4_1773433529.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,724 Read SEC document |
| March 10, 2026 Filed Mar 11, 2026 22:22 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | SaleCommon Stock | 500 | $15.30 | $7,650.00 |
DisclosureSEC source: 0001193125-26-102581 · ownership.xml · nonDerivative · entry 4 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,406 F1 · security: The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors. Read SEC document |
| March 10, 2026 Filed Mar 11, 2026 22:22 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | SaleCommon Stock | 500 | $15.57 | $7,782.60 |
DisclosureSEC source: 0001193125-26-102581 · ownership.xml · nonDerivative · entry 3 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,906 F1 · security: The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors. Read SEC document |
| March 10, 2026 Filed Mar 11, 2026 22:22 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | SaleCommon Stock | 300 | $15.28 | $4,584.66 |
DisclosureSEC source: 0001193125-26-102581 · ownership.xml · nonDerivative · entry 2 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,406 F1 · security: The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 12:12 UTC | Indivior Pharmaceuticals, Inc. INDV · Entity 4040 | PurchaseCommon Stock | 31 | $32.56 | $1,009.36 |
DisclosureSEC source: 0001827169-26-000008 · wk-form4_1773231148.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,716 Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 22:22 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | SaleCommon Stock | 200 | $10.17 | $2,034.50 |
DisclosureSEC source: 0001193125-26-102581 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,706 F1 · security: The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:45 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | SaleCommon Stock | 100 | $10.83 | $1,082.58 |
DisclosureSEC source: 0001193125-26-091707 · ownership.xml · nonDerivative · entry 2 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,906 Read SEC document |
| March 02, 2026 Filed Jun 2, 2026 20:05 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantCommon Stock | 1,629 | $10.90 | $17,756.10 |
DisclosureSEC source: 0001193125-26-253470 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,035 F2 · price: Due to an administrative error, the RSUs for Q1 2026 Board and committee compensation were not filed timely. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 21:45 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | SaleCommon Stock | 400 | $10.86 | $4,343.32 |
DisclosureSEC source: 0001193125-26-091707 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,006 Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 21:10 UTC | Indivior Pharmaceuticals, Inc. INDV · Entity 4040 | GrantCommon Stock | 3,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001827169-26-000006 · wk-form4_1769634606.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,685 F1 · shares: Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the first annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 18:51 UTC | Indivior Pharmaceuticals, Inc. INDV · Entity 4040 | PurchaseOrdinary Shares | 775 | $35.39 | $27,429.27 |
DisclosureSEC source: 0001827169-26-000004 · wk-form4_1767811905.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,963 F1 · kind: Securities acquired pursuant to the director's participation in a Non-Executive Director Purchase Plan to receive a portion of the fees received for service as a director in stock in lieu of cash. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:22 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantStock Option (Right to Buy) · Derivative | 5,395 | $0.00 Strike: $11.12 | $0.00 |
DisclosureSEC source: 0001193125-26-004779 · ownership.xml · derivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,395 Underlying: Common Stock · 5,395 shares Expires 2036-01-02 F1 · derivative.exercise_date: Option vests on February 2, 2026, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date. Read SEC document |
| December 19, 2025 Filed Dec 22, 2025 22:28 UTC | Azitra, Inc. AZTR · Entity 7959 | GrantStock Options (Right To Buy) · Derivative | 3,003 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001493152-25-028845 · ownership.xml · derivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,003 Underlying: Common Stock · 3,003 shares Expires 2035-12-19 F1 · derivative.exercise_date: 25% of the shares of the Company's Common Stock subject to the Option shall vest on the date of issuance, the Vesting Commencement Date, and the remaining balance shall vest in equal monthly installments over the next 36 months of continuous service thereafter. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 21:10 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantCommon Stock | 1,601 | $11.09 | $17,755.09 |
DisclosureSEC source: 0001193125-25-306678 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,406 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. Read SEC document |
| September 09, 2025 Filed Sep 11, 2025 20:05 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantStock Option (Right to Buy) · Derivative | 3,225 | $0.00 Strike: $15.36 | $0.00 |
DisclosureSEC source: 0001193125-25-201313 · ownership.xml · derivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,225 Underlying: Common Stock · 3,225 shares Expires 2035-09-09 F1 · derivative.exercise_date: The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date. Read SEC document |
| September 02, 2025 Filed Sep 3, 2025 21:29 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantCommon Stock | 1,281 | $13.86 | $17,754.66 |
DisclosureSEC source: 0001193125-25-195090 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,805 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. Read SEC document |
| August 26, 2025 Filed Aug 29, 2025 01:18 UTC | INVO Fertility, Inc. IVF · Entity 8473 | GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.01 | $0.00 |
DisclosureSEC source: 0001641172-25-025868 · ownership.xml · derivative · entry 2 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,157 Underlying: Common Stock · 45,000 shares Expires 2035-08-26 F1 · derivative.exercise_date: The option vests in four equal installments beginning on the first day of the calendar quarter following August 26, 2025 and on the first day of each calendar quarter thereafter until fully vested. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:05 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantCommon Stock | 2,476 | $7.17 | $17,752.92 |
DisclosureSEC source: 0000950170-25-081608 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,524 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:05 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantCommon Stock | 2,019 | $8.79 | $17,747.01 |
DisclosureSEC source: 0000950170-25-033523 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,048 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 15:44 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantCommon Stock | 24,229 | $0.73 | $17,687.17 |
DisclosureSEC source: 0000950170-24-132525 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,336 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 12:23 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantCommon Stock | 21,649 | $0.82 | $17,752.18 |
DisclosureSEC source: 0000950170-24-103750 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,107 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 18:27 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantCommon Stock | 17,841 | $0.99 | $17,662.59 |
DisclosureSEC source: 0000950170-24-069215 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,458 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:00 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantCommon Stock | 18,685 | $0.95 | $17,750.75 |
DisclosureSEC source: 0000950170-24-026422 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,617 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 23:11 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantCommon Stock | 17,068 | $1.04 | $17,750.72 |
DisclosureSEC source: 0000950170-23-068322 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,932 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. Read SEC document |
| September 08, 2023 Filed Oct 3, 2023 20:05 UTC | Azitra, Inc. AZTR · Entity 7959 | GrantStock Options (Right To Buy) · Derivative | 10,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001493152-23-035228 · ownership.xml · derivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-09-08 F1 · derivative.exercise_date: 25% of the shares of the Company's Common Stock subject to the Option shall vest after 12 months of continuous service measured from 06/21/2023, the Vesting Commencement Date, and the remaining balance shall vest in equal monthly installments over the next 36 months of continuous service thereafter. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 21:01 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantCommon Stock | 12,158 | $1.46 | $17,750.68 |
DisclosureSEC source: 0000950170-23-046774 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,864 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. F2 · balance_after: In Table 1 of the Form 4 filed on June 2, 2023, the amount of securities acquired and price (column 4) and amount of securities beneficially owned following reported transaction (column 5) were erroneously reported. On June 1, 2023, 9,862 RSUs were acquired at a price of $1.80 each, resulting in a total amount of securities beneficially owned following the reported transaction of 38,706 instead of 38,930 as erroneously reported. Read SEC document |
| June 14, 2023 Filed Jun 17, 2023 00:13 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantStock Option (Right to Buy) · Derivative | 37,500 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0000899243-23-015849 · doc4.xml · derivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2033-06-14 F1 · derivative.exercise_date: The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 23:42 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantCommon Stock | 10,086 | $1.76 | $17,751.36 |
DisclosureSEC source: 0000899243-23-014414 · doc4.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,930 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. Read SEC document |
| May 18, 2023 Filed May 23, 2023 00:07 UTC | INVO Fertility, Inc. INVO · Entity 8473 | GrantStock Option (right to buy) · Derivative | 85,000 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001493152-23-018625 · ownership.xml · derivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2033-05-17 F1 · derivative.exercise_date: The option vests in four equal installments beginning on May 17, 2023 and on each calendar quarter-end thereafter until fully vested. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 19:58 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantCommon Stock | 8,493 | $2.09 | $17,750.37 |
DisclosureSEC source: 0000899243-23-006913 · doc4.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,844 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:18 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantCommon Stock | 6,801 | $2.61 | $17,750.61 |
DisclosureSEC source: 0000899243-22-037650 · doc4.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,351 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 23:02 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantCommon Stock | 13,550 | $2.62 | $35,501.00 |
DisclosureSEC source: 0000899243-22-031529 · doc4.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,550 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 22:45 UTC | INVO Fertility, Inc. INVO · Entity 8473 | PurchaseCommon Stock | 10,526 | $0.95 | $9,999.70 |
DisclosureSEC source: 0001493152-22-015911 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,991 Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:11 UTC | MiNK Therapeutics, Inc. INKT · Entity 52 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.89 | $0.00 |
DisclosureSEC source: 0000899243-22-010704 · doc4.xml · derivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-03-09 F1 · derivative.exercise_date: The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date. Read SEC document |
| January 15, 2022 Filed Jan 19, 2022 02:26 UTC | INVO Fertility, Inc. INVO · Entity 8473 | GrantStock Option · Derivative | 10,435 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001493152-22-001529 · ownership.xml · derivative · entry 2 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,435 Underlying: Common Stock · 10,435 shares Expires 2032-01-14 F1 · derivative.exercise_date: The stock option vests in monthly increments over a period of twelve months from the date of grant. Read SEC document |
| January 15, 2022 Filed Jan 19, 2022 02:26 UTC | INVO Fertility, Inc. INVO · Entity 8473 | GrantCommon Stock | 8,588 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-001529 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,053 Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:05 UTC | INVO Fertility, Inc. INVO · Entity 8473 | GrantStock Option · Derivative | 13,574 | $0.00 Strike: $3.06 | $0.00 |
DisclosureSEC source: 0001185185-21-000018 · ownership.xml · derivative · entry 2 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,574 Underlying: Common Stock · 13,574 shares Expires 2030-12-31 F1 · derivative.exercise_date: The restricted stock and the option vest in monthly increments over a period of twelve months from the date of grant. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:05 UTC | INVO Fertility, Inc. INVO · Entity 8473 | GrantRestricted Stock | 10,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-21-000018 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,465 F1 · security: The restricted stock and the option vest in monthly increments over a period of twelve months from the date of grant. Read SEC document |
| November 27, 2020 Filed Dec 1, 2020 22:30 UTC | INVO Fertility, Inc. INVO · Entity 8473 | GrantStock Option · Derivative | 2,317 | $0.00 Strike: $3.19 | $0.00 |
DisclosureSEC source: 0001185185-20-001693 · ownership.xml · derivative · entry 2 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,317 Underlying: Common Stock · 2,317 shares Expires 2025-11-27 Read SEC document |
| November 27, 2020 Filed Dec 1, 2020 22:30 UTC | INVO Fertility, Inc. INVO · Entity 8473 | GrantCommon Stock | 2,317 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-20-001693 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,317 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.